1. Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies

   • Jennifer G. Gaultney
   • Jacoline C. Bouvy
   • Andrew H. Briggs

   Current Opinion 24 May 2021 Pages: 625 - 634

   

2. Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?

   • Patricia Cubi-Molla
   • Martin Buxton
   • Nancy Devlin

   Current Opinion Open access 09 June 2021 Pages: 635 - 644

   

3. A Review of Web-Based Tools for Value-of-Information Analysis

   • Haitham Tuffaha
   • Claire Rothery
   • Stephen Birch

   Review Article 28 May 2021 Pages: 645 - 651

4. ‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions

   • Rhiannon Tudor Edwards
   • Catherine Louise Lawrence

   Review Article Open access 31 May 2021 Pages: 653 - 664

   

5. The PLASMA System for Transurethral Resection of the Prostate: A NICE Medical Technologies Guidance Update

   • Laura Knight
   • Susan Peirce
   • Rhys Morris

   Review Article 26 April 2021 Pages: 665 - 672

6. A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks

   • Janetta E. Skarp
   • Laura E. Downey
   • Katharina Hauck

   Systematic Review Open access 11 June 2021 Pages: 673 - 697

   

7. Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines

   • Christian Alvin H. Buhat
   • Destiny S. M. Lutero
   • Jomar F. Rabajante

   Original Research Article 25 June 2021 Pages: 699 - 708

   

8. How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran

   • Enayatollah Homaie Rad
   • Mohammad Hajizadeh
   • Zahra Mohtasham-Amiri

   Original Research Article 27 July 2021 Pages: 709 - 719

   

9. The Impact of Financing Health Services on Income Inequality in an Unequal Society: The Case of South Africa

   • John E. Ataguba

   Original Research Article 19 May 2021 Pages: 721 - 733

   

10. Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom

    • Han Geul Byun
    • Minyoung Jang
    • Taek Sang Kwon

    Original Research Article 12 August 2021 Pages: 735 - 745

    

11. Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study

    • Victoria K. Brennan
    • Georgina Jones
    • Simon Dixon

    Original Research Article 30 March 2021 Pages: 747 - 756

    

12. Consumers' Preferences and Willingness to Pay for Personalised Nutrition

    • Daniel Pérez-Troncoso
    • David M. Epstein
    • José A. Castañeda-García

    Original Research Article 26 April 2021 Pages: 757 - 767

    

13. Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data

    • Jeetendra Yadav
    • Geetha R. Menon
    • Denny John

    Original Research Article 22 February 2021 Pages: 769 - 782

    

14. Comment on: “Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data”

    • Nafis Faizi
    • Yasir Alvi

    Letter to the Editor 27 April 2021 Pages: 783 - 784